Transgenomic (TBIO) Tops Q3 EPS by 9c

Go back to Transgenomic (TBIO) Tops Q3 EPS by 9c

Transgenomic Reports Third Quarter 2015 Financial Results

November 12, 2015 4:06 PM EST

Conference Call to Be Held at 5:00 PM Eastern Time Today

OMAHA, Neb.--(BUSINESS WIRE)-- Transgenomic, Inc. (NASDAQ: TBIO) today reported financial results for the third quarter ended September 30, 2015, and provided a business update.

Business UpdateDuring the third quarter of 2015, Transgenomic continued its strategic refocusing on precision medicine and the commercialization of its ICE COLD-PCR technology. The Company announced that it had sold certain assets and liabilities of its ion chromatography columns business and additionally announced that it had entered into a binding term sheet to divest the remaining... More

Transgenomic to Hold Third Quarter Financial Results Conference Call on November 12, 2015 at 5:00PM ET

November 11, 2015 4:33 PM EST

OMAHA, Neb.--(BUSINESS WIRE)-- Transgenomic, Inc. (NASDAQ: TBIO), today announced that the company will hold its Third Quarter 2015 Financial Results and Business Update Conference Call on Thursday, November 12, 2015 at 5:00 PM ET. The company will present an overview of financial results for the third quarter in a press release issued after the market close that day.

To... More